Spotting cutting-edge topics in scientific research using keyword analysis

Researchers have conducted a quantitative keyword analysis of 30 million articles in the life sciences over a nearly fifty-year period (1970-2017) and found that 75% of total emerging keywords, at 1-year prior to becoming identified as emerging, co-appeared with other emerging keywords in the same article.

Read more

The spectrum of arrogance

A team of psychology researchers is providing one of the first comprehensive literature reviews on arrogance, as well as a way to classify the condition on different levels across a spectrum, similarly to how autism is diagnosed. The team acknowledges everyone seems to have some degree of arrogance, so in addition to the literature review, the researchers suggest a way to classify the different levels of arrogance a person could exhibit.

Read more

Frailty: The rising global health burden for an aging society

Despite the evidence on risk factors for frailty, and the substantial progress that has been made in frailty awareness, the biological mechanisms underlying its development are still far from understood and translation from research to clinical practice remains a challenge. A new article provides an up-to-date clinical overview on preventing, identifying and managing frailty as well as its global impact and burden.

Read more

New genetic-based epilepsy risk scores

An international team of researchers has developed new genetic-based epilepsy risk scores which may lay the foundation for a more personalized method of epilepsy diagnosis and treatment. This analysis is the largest study of epilepsy genetics to date, as well as the largest study of epilepsy using human samples.

Read more

Targeting certain rogue T cells prevents and reverses multiple sclerosis in mice

Multiple sclerosis, an autoimmune disorder, is known to be driven by 'helper' T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them. An antibody targeting CXCR6 both prevented and reversed MS in a mouse model, the researchers report.

Read more